:

NURO CLEARS DRIVERLESS TESTING FOR UBER ROBOTAXIS

INDUSTRY DESK2 MIN READ
MON, MAY 25, 2026

■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE

Nuro has received approval to test fully autonomous vehicles on California roads as part of its partnership with Uber. The Silicon Valley startup plans to begin driverless testing later this year.

Nuro secured the necessary permit to operate driverless vehicles in California, clearing the path for autonomous Uber robotaxi testing. The startup has not yet commenced driverless operations but is now authorized to do so. The testing phase represents a significant milestone for both Nuro and Uber. The two companies have partnered to deploy autonomous ride-hailing services, with plans to launch full driverless testing in California before year's end. Nuro specializes in autonomous vehicle technology and has been operating in the autonomous vehicle space for several years. The company's expertise in self-driving systems positions it as a key player in Uber's broader robotaxi expansion strategy. California's approval demonstrates that Nuro has met the state's safety and technical requirements for driverless vehicle testing. The permit is a prerequisite for conducting real-world autonomous operations on public roads. Uber has pursued robotaxi services across multiple markets and has partnered with various autonomous vehicle companies to accelerate development. The Nuro collaboration expands Uber's autonomous capabilities and diversifies its technology partners. The testing program will provide data on vehicle performance, safety protocols, and operational efficiency. Results from California testing could inform future deployments in other states and markets. No timeline for commercial launch has been announced, though both companies indicated testing would occur in 2024. The pace of subsequent rollout will depend on performance metrics and regulatory feedback during the testing phase.

■ SOURCES

TechCrunchEngadget

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

12H AGOAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

12H AGOAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

20H AGOAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.